News

Elderly Patients With Myeloma Still Candidates for Transplant

Despite concerns, elderly patients with myeloma should not have autologous stem cell transplantation (ASCT) written off as one of their treatment options, according to Andrew L. Pecora, M.D. In an interview with OncLive, a sister publication of CURE, Pecora – who is president of the Physician Services and chief innovation officer at Hackensack Meridian Health – discussed findings of a recent study conducted at the John Theurer Cancer Center that involved 604 patients – 44 of whom were between the ages of 75 and 84 – who underwent ASCT.

READ FULL ARTICLE CURETODAY.COM